Mozavaptan-d6, CAS 2750534-83-7

Product Description: Mozavaptan-d6 (OPC-31260-d6) is the deuterium labeled Mozavaptan. Mozavaptan (OPC-31260) is a benzazepine derivative and a potent, selective, competitive and orally active vasopressin V2 receptor antagonist with an IC50 of 14 nM. Mozavaptan shows ~85-fold selectivity for V2 receptor over V1 receptor (IC50 of 1.2 μM), and can antagonize the antidiuretic action of arginine vasopressin (AVP) in vivo. Mozavaptan has the potential for hyponatremia, syndrome of inappropriate antidiuretic hormone (SIADH), and congestive heart failure treatment[1][2].

Formula: C27H23D6N3O2

References: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. /[2]Yamamura Y, et al. Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. Br J Pharmacol. 1992 Apr;105(4):787-91./[3]Yamaguchi K, et al. Clinical implication of the antidiuretic hormone (ADH) receptor antagonist mozavaptan hydrochloride in patients with ectopic ADH syndrome. Jpn J Clin Oncol. 2011 Jan;41(1):148-52.

CAS Number: 2750534-83-7

Molecular Weight: 433.58

Research Area: Cancer; Endocrinology; Metabolic Disease

Solubility: 10 mM in DMSO

Target: Isotope-Labeled Compounds;Vasopressin Receptor

• Artikelnummer: MEXHY-18346S-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-18346S-5
• Verpackungseinheit: 5mg
• Mengeneinheit: STK